子宮線維腫の治療におけるビタミンDとエピガロケチンガラート (EGCG) の可能性:インビトロから臨床試験までの証拠

Ioanna Ploumaki¹, Samya El Sayed², Awurakua Asamoah-Mensah²

¹School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Molecular nutrition & food research

|September 1, 2025

まとめ

ビタミンDとEGCGは子宮筋腫の治療に有望な効果を示していますこれらの天然化合物を組み合わせることで線維細胞のサイズを縮小し生活の質を向上させる非侵襲的な方法が提供されます

科学分野:

生殖生物学と内分泌学
栄養学
腫瘍学

背景:

子宮線維腫は一般的な良性腫瘍で,重大な罹患率を引き起こします.
ビタミンDとEGCG (epigallocatechin gallate) は,個別に抗線維菌性があることが示されています.
相互補完的なメカニズムは連携効果の可能性を示唆している.

研究の目的:

子宮線維腫におけるビタミンDとEGCGの作用メカニズムを見直す.
薬の有効性に関する臨床前および臨床的証拠を提示する.
子宮筋腫の併用療法の可能性を議論する.

主な方法:

臨床前 (in vitro,in vivo) と臨床研究の文献レビュー
細胞増殖,アポトーシス,繊維症を含むビタミンDとEGCGのメカニズムに関するデータの合成.
ビタミンDとEGCGを併用した臨床試験の分析

主要な成果:

ビタミンDとEGCGはそれぞれ子宮線維細胞の増殖を抑制し,アポトーシスを促進する.
臨床研究によるとビタミンDは線維腫の発生,体積,成長率を減少させます
EGCGは線維腫の治療にも潜在性を示しており,臨床試験でその有効性が確認されています.
初期データによると併用療法により線維腫の体積が減り,生活の質が改善されています.

結論:

ビタミンDとEGCGは補完的なメカニズムで有望な抗線維菌活性を示しています.
併用治療は,子宮線維腫に対する非侵襲的で費用対効果の高い戦略です.
併用治療の最適な使用と有効性を確立するために,さらなる臨床試験が必要である.

キーワード:

EGCG 臨床試験グリーンティー子宮線維腫ビタミンD

さらに関連する動画

06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K

06:00

Optimization of the Epimedii Folium Mutton-Oil Processing Technology and Testing Its Effect on Zebrafish Embryonic Development

Published on: March 17, 2023

553

関連する概念動画

02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

関連する実験動画